Document is current

Any future updates will be listed below

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12879-016-1790-x

Published Online: 2016-08-27

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark